Member Info for Beamer21

Not sure if previously posted...

https://www.readitquik.com/articles/iot-2/10-iot-security-firms-to-watch-for/

appears to be 14.5p

so no new shockers

Bad day for the markets though....

The independent article is from 31st August

Trek

I think the Heathrow testing that’s currently being reported is managed by Collinson using a saliva lamp test - I think this may well be OptiGene who have successfully been running trials in conjunction with Southampton hospital/council and uni

It also now appears that OptiGene is rolling out more testing in Manchester too

Now idea what’s happening with iAbra

Further info on bond covenants etc https://www.ipfin.co.uk/en/investors/consent-solicitation-for-bonds.html

These rates are the sign of the times it seems thanks to Covid

are positive given the situation and demonstrates Amigo and FCA are working cohesively to an agreed outcome

VREQ currently in place governing complaint handling - expires 30/10 so expect an update and possible extension

Bump this great post up from ShiftingShares

https://www.shiftingshares.com/what-is-a-rights-issue/

It’s somewhat futile attempting to analyse and evaluate the relevance of late/delayed trades as they are typically worked over a period of time

Let’s see what happens in the morning. It would be good if this afternoon was their final push down and they finish closing

They’ve been steadily closing...... was this afternoon their final closing out parade?

They were down to 0.61% on Friday 9th October

Very happy with my recent purchase

Buying opportunity created presumably by Miton taking some profit and selling into the rise

https://www.telegraph.co.uk/news/2020/09/25/china-prepares-declare-victory-global-vaccine-race-assures/

Pre Covid TTG were trading at 240 - 250p

I really don’t think that’s the case, I agree the timing of the acquisition and placing is fortuitous however this would have been set in motion a long time ago and in fact it’s quite probable that the placing may actually have been at a slight premium as TTG was trading around 190 recently prior to the iAbra collaboration

iAbra appear to have been thrown into the spotlight as a result of their successful trials at Heathrow airport and the associated press . To be fair TTG announced their manufacturing agreement earlier this month and even on the most recent communication detailing the launch they confirmed that although they had received orders totalling £2m the potential £280m was subject to regulatory approval - with iAbra receiving so much press it looks as though TTG were forced to notify the market

I hold and am currently underwater, however, with or without iAbra I’m confident that my money will see a decent return, however, I’m naturally hoping that we do indeed see £280m + orders of Virolens as this revenue would make the most recent highs look very cheap

TTG is not a pure Covid play which is what makes it interesting

A few days of turbulence but with potential blue skies ahead

this was trading at around 190p so all things considered 200p is reasonably fair for the acquisition - onwards and upwards

We continue to manage the wind down of our legacy business, focusing on rightsizing the operations to the lower volumes, generating positive cash flow and exploring options to realise value in our proprietary payments technology. This leaves our balance sheet robust and our strategic efforts focused on realising further value for shareholders via our holding in Clearpay."

Trek - I don’t disagree at all. iAbra should make a statement

Just a load of sound bites with no real context other than a die hard attempt by the FT journalist to discredit iAbra and their technology

TTG have communicated appropriately and are simply the manufacturing partner who have consistently stated that sales are subject to approvals however orders worth £2m have been placed to date with September/October delivery